Your browser doesn't support javascript.
loading
Nucleotide excision repair is a potential therapeutic target in multiple myeloma.
Szalat, R; Samur, M K; Fulciniti, M; Lopez, M; Nanjappa, P; Cleynen, A; Wen, K; Kumar, S; Perini, T; Calkins, A S; Reznichenko, E; Chauhan, D; Tai, Y-T; Shammas, M A; Anderson, K C; Fermand, J-P; Arnulf, B; Avet-Loiseau, H; Lazaro, J-B; Munshi, N C.
Afiliação
  • Szalat R; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Samur MK; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Fulciniti M; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lopez M; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Nanjappa P; VA Boston Healthcare System, West Roxbury, MA, USA.
  • Cleynen A; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Wen K; CNRS, UMR 5149, Institut Montpelliérain Alexander Grothendieck, Université de Montpellier, Montpellier, France.
  • Kumar S; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Perini T; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Calkins AS; Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Reznichenko E; Department of Radiation Oncology, Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Chauhan D; Department of Radiation Oncology, Center for DNA Damage and Repair, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Tai YT; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Shammas MA; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Anderson KC; VA Boston Healthcare System, West Roxbury, MA, USA.
  • Fermand JP; Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Arnulf B; Departement d'Immunologie Hematologie, Hopital Saint-Louis, Paris, France.
  • Avet-Loiseau H; Departement d'Immunologie Hematologie, Hopital Saint-Louis, Paris, France.
  • Lazaro JB; INSERM, UMR 1126, Institut Universitaire d'Hématologie, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
  • Munshi NC; Unité de Génomique du Myélome, University Hospital, Toulouse, France.
Leukemia ; 32(1): 111-119, 2018 01.
Article em En | MEDLINE | ID: mdl-28588253
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reparo do DNA / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reparo do DNA / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article